CClinicalTrials.gg
CompletedNCT07339410Updated Jan 14, 2026

Physiotherapy to Improve Balance and Walking Capacity in Hemophilia

An interventional study of Physiotherapy in Hemophilia, sponsored by Yuzuncu Yil University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by Yuzuncu Yil University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Male
01

Study summary

Introduction: Hemarthrosis is the most common type of bleeding with 70-80% in patient with hemophilia (PwH) and the majority of hemarthrosis occurs in the knee and ankle joints. Recurrent hemarthrosis may cause pain, limited range of motion (ROM), atrophy, swelling, crepitus, and decreased proprioceptive sensation and ultimately causes hemophilic arthropathy. Preventing hemarthrosis and treating arthropathy symptoms in PwH may improve static and dynamic balance and walking capacity. The aim of this study was to investigate the effects of manual therapy and structured exercises on joint health, activity pain, walking capacity and static and dynamic balance.

Method: Thirty-five AwH were randomly assigned to two groups using the computerised simple randomization method: the control group (CG) and the physiotherapy group (PG). The sample sizes for the CG and PG are 17 and 18, respectively. Hemophilia type and severity, treatment regime (prophylaxis or on-demand), age, height and weight were recorded. Joint health was assessed with Hemophilia Joint Health Score (HJHS) version 2.1 by a hemophilia specialist physiotherapist. Activity pain was assessed with Numeric Pain Scale (NPS). Walking capacity was evaluated 6 Minute Walking Test (6MWT). Postural balance (static and dynamic balance) were evaluated with the Pro-kin Technobody Posturographic Platform (Pro-kin 212, Technobody s.r.l, Dalmine, 21044 Bergamo, Italy). Static stability test was used for static balance assessment. Dynamic balance was evaluated with the Limits of Stability (LoS) test. The PG received 12 physiotherapy sessions twice a week for 6 weeks. The physiotherapy intervention consisted of manual therapy and a structured, progressive exercise program. The CG continued with their routine hemophilia care.

02

Conditions studied

  • Hemophilia

Keywords

  • Manual therapy
  • Exercise
  • Postural balance
  • walking
  • hemophilia
  • arthropathy
03

In context

Hemophilia A

866 studies on the registry are indexed under Hemophilia A; 137 are open to participants now.

This study's enrollment of 35 is above the median of 28 across 512 interventional studies indexed under Hemophilia A.

Browse Hemophilia A studies →

Lead sponsor

Yuzuncu Yil University is the lead sponsor of 66 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Severe or moderate hemophilia A or B
  • Aged 18-65
  • Having at least 3 points from at least one of the knee and ankle index joints in the Hemophilia Joint Health Score
  • Volunteering to attend physiotherapy sessions regularly

Exclusion criteria

Exclusion Criteria:

  • Receiving physiotherapy or undergone surgery on lower extremity within the last 6 months
  • Having neurological or cognitive disease
  • Having visual and vestibular system pathologies
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • No intervention
    Control Group
  • Experimental
    Physiotherapy Group

    Physiotherapy

    Other: Physiotherapy

Interventions

  • OtherPhysiotherapy

    The physiotherapy intervention applied in this study included manual therapy and a structured and progressive exercise program.

06

What researchers measure

Primary outcomes

  1. Postural balance

    Static and dynamic postural balance were evaluated with the Pro-kin Technobody Posturographic Platform (Pro-kin 212, Technobody s.r.l, Dalmine, 21044 Bergamo, Italy).

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Walking capacity

    Walking capacity was evaluated with 6 Minute Walking Test.

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. Activity pain

    Activity pain was evaluated with Numeric Pain Scale

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Joint health

    Joint health was evaluated with Hemophilia Joint Health Score

    Time frame: From enrollment to the end of treatment at 6 weeks

07

Study locations

1 site
  • Van Yüzüncü Yıl University
    Van, 65080, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07339410
Lead sponsor
Yuzuncu Yil University
Responsible party
Ayse Merve TAT (Assistant Professor, Yuzuncu Yil University) — Principal investigator
First posted
Jan 14, 2026
Start date
Oct 20, 2025
Primary completion
Dec 20, 2025
Completion
Jan 5, 2026
Last update
Jan 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion